Open AccessMiddle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled study
Author(s) -
Özgür Akın Oto,
Savaş Öztürk,
Mustafa Arıcı,
Arzu Velioğlu,
Belda Dursun,
Nurana Guller,
İdris Şahi̇n,
Zeynep Ebru Eser,
Saime Paydaş,
Sinan Trabulus,
Sümeyra Koyuncu,
Murathan Uyar,
Zeynep Ural,
Rezzan Eren Sadioğlu,
Hamad Dheir,
Neriman Sıla Koç,
Hakan Özer,
Beyza Algül Durak,
Cuma Bülent Gül,
Umut Sabri Kasapoğlu,
Ebru Gök Oğuz,
Mehmet Tanrısev,
Gülşah Şaşak Kuzgun,
Şafak Mirioğlu,
Erkan Dervişoğlu,
Ertuğrul Erken,
Numan Görgülü,
Sultan Özkurt,
Zeki Aydın,
İlhan Kurultak,
Melike Betül Öğütmen,
Serkan Bakırdöğen,
Burcu Kaya,
Serhat Karadağ,
Memnune Sena Ulu,
Özkan Güngör,
Elif Arı Bakır,
Ali Rıza Odabaş,
Nurhan Seyahi,
Alaattin Yıldız,
Kenan Ateş
Publication year - 2022
Publication title -
clinical kidney journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 40
eISSN - 2048-8513
pISSN - 2048-8505
DOI - 10.1093/ckj/sfac045
Subject(s) - medicine , interquartile range , clinical endpoint , covid-19 , viremia , gastroenterology , clinical trial , immunology , disease , infectious disease (medical specialty) , human immunodeficiency virus (hiv)
In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group.